Compound Name (alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM10330
 | 1 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(4-Methoxybenzyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(4-methoxyphenyl)methyl]-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- CHEMBL200677
- Pyrrolidine Isatin Analogue 11b
|
BDBM10334
 | 1 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(4-Hydroxybenzyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(4-hydroxyphenyl)methyl]-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- CHEMBL200927
- Pyrrolidine Isatin Analogue 11f
|
BDBM10355
 | 4 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- hIL-1beta
| - (3S)-3-[(2S)-2-[(2S)-2-[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]propanamido]-4-oxobutanoic acid
- Ac-YVAD-CHO
- CHEMBL37630
|
BDBM103796
 | 9 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | - Beta-2 adrenergic receptor
- Muscarinic acetylcholine receptor M3
| - US8551978, 322
- US8551978, 323
- US8816088, I-66
- US8816088, I-67
- US9394275, I-66
- US9572802, Compound I-67
- US9682957, I-67
|
BDBM104213
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Serine/threonine-protein kinase PIM-3
- Serine/threonine-protein kinase pim-1
- Serine/threonine-protein kinase pim-2
| - US8575145, 120
- US8575145, 121
- US8575145, 150
- US8575145, 151
- US8575145, 90
- US8575145, 91
|
BDBM10458
 | 4 | 6 | 1 | 1 | 0 | 0 | 0 | 0 | - Acetylcholinesterase
- Carboxylic ester hydrolase
- Choline transporter
- Plasminogen
- Potassium voltage-gated channel subfamily H member 2
- Prothrombin
- Pteridine reductase 1
- Trypsin
- Twik-RElated Potassium (K+) channel 1 (TREK1)
- Voltage-gated potassium channel
- Voltage-gated potassium channel subfamily A member 1/beta-1
| - 4-AP
- 4-Aminopyridine 10
- CHEMBL284348
- DALFAMPRIDINE
- pyridin-4-amine
|
BDBM106722
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Nitric oxide synthase, brain
- Nitric oxide synthase, endothelial
- Nitric oxide synthase, inducible
- Sodium-dependent noradrenaline transporter
| - CHEMBL2036264
- US8586620, 114
|
BDBM106896
 | 9 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Serine/threonine-protein kinase pim-1
- Serine/threonine-protein kinase pim-2
- Serine/threonine-protein kinase pim-3
| |
BDBM106950
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - CDK2/CycE
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 5 (CDK5)
- Cyclin-Dependent Kinase 7 (CDK7)
- Cyclin-Dependent Kinase 9 (CDK9)
- Cyclin-dependent kinase 2
- Cyclin-dependent kinase 4/G1/S-specific cyclin-E1
- Cyclin-dependent kinase 9
- Cyclin-dependent-like kinase 5
| |
BDBM107486
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 11-beta-hydroxysteroid dehydrogenase 1
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 3A
| - US8575157, 200
- US8592410, Comparator 12
- US8598163, 70
|
BDBM10844
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Axin-1/Glycogen synthase kinase-3 beta
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 5 (CDK5)
- Dual specificty protein kinase CLK1
- Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
- Dual-specificity tyrosine-phosphorylation regulated kinase 1A
- Glycogen Synthase Kinase-3, beta
- Mitogen-activated protein kinase kinase kinase 14
- cAMP-Dependent Protein Kinase (PKA)
- cGMP-Dependent Protein Kinase
| - 4-(1H-indol-3-yl)pyrimidin-2-amine
- Meridianin G
|
BDBM10854
 | 1 | 3 | 8 | 0 | 0 | 0 | 0 | 0 | - Chitinase 1
- Chitinase B
- Chitinase Mutant (A217G)
- Chitinase Mutant (D175A)
- Chitinase Mutant (E322A)
- Chitinase Mutant (M243A)
- Chitinase Mutant (R301K)
- Chitinase Mutant (T138A)
- Chitinase Mutant (Y245F)
- Endochitinase B1
| - 4-[(1S,4R,10S,13S,16S,18R)-10-{3-[(acetamidomethanimidoyl)amino]propyl}-18-hydroxy-16-(1H-imidazol-4-ylmethyl)-3,9,12,15,20-pentaoxo-2,8,11,14,17-pentaazatricyclo[15.2.1.0^{4,8}]icosan-13-yl]butanoic acid
- Argadin
- CHEMBL445236
|
BDBM108945
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Activin receptor type-1
- Activin receptor type-1B
- Activin receptor type-1B/Activin receptor-like kinase 4 (ALK-4)
- Activin receptor-like kinase 3 (ALK-3)
- Bone morphogenetic protein receptor type-1B (BMPR1B) aa 168-495
- Serine/threonine-protein kinase receptor R3
- Serine/threonine-protein kinase receptor R3 (ALK1)
- TGF-beta receptor type-1
| - US10017516, Compound 48
- US9682983, 48
|
BDBM11140
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Dipeptidyl peptidase 2 (DPP II)
- Dipeptidyl peptidase 4
- Dipeptidyl peptidase 9
- Dipeptidyl peptidase VIII
| - (1S,2S)-1-(dimethylcarbamoyl)-1-[4-(4-fluorophenyl)phenyl]-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropan-2-aminium; 2,2,2-trifluoroacetate
- beta-dimethylamide 4
- beta-substituted phenylalanine deriv. 22
- phenylalanine derived inhibitor, 3
|
BDBM11189
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Dipeptidyl peptidase 2 (DPP II)
- Dipeptidyl peptidase 4
- Dipeptidyl peptidase 9
- Dipeptidyl peptidase VIII
| - (2S,3S)-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-aminium; 2,2,2-trifluoroacetate
- 3-(S)-fluoropyrrolidide 25
- beta-substituted phenylalanine deriv. 14
- phenylalanine derived inhibitor, 4
|
BDBM11343
 | 10 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | - 72 kDa type IV collagenase
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Collagenase (ChC)
- Interstitial collagenase
- Matrix metalloproteinase 12
- Matrix metalloproteinase-9
- Neutrophil collagenase
| - (2S)-2-[benzyl(4-methoxybenzene)sulfonamido]-N-hydroxy-3-methylbutanamide
- Hydroxamate 24
- N-4-Methoxyphenylsulfonyl-N-benzyl-L-valine hydroxamate
|
BDBM11362
 | 11 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - 72 kDa type IV collagenase
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Collagenase (ChC)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
| - 2-{[(2-chlorophenyl)methyl](1,1,2,2,3,3,4,4,4-nonafluorobutane)sulfonamido}-N-hydroxypropanamide
- Hydroxamate 43
- hydroxamate deriv. B4
|
BDBM11363
 | 11 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - 72 kDa type IV collagenase
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Collagenase (ChC)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
| - 2-{[(2-chlorophenyl)methyl](2,3,4,5,6-pentafluorobenzene)sulfonamido}-N-hydroxypropanamide
- Hydroxamate 44
- hydroxamate deriv. B21
|
BDBM11364
 | 11 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - 72 kDa type IV collagenase
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Collagenase (ChC)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
| - 2-{[(2-chlorophenyl)methyl](4-methoxybenzene)sulfonamido}-N-hydroxypropanamide
- Hydroxamate 45
- hydroxamate deriv. B24
|
BDBM11719
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Dipeptidyl peptidase 2 (DPP II)
- Dipeptidyl peptidase 4
- Dipeptidyl peptidase 9
- Dipeptidyl peptidase VIII
- Fibroblast Activation Protein (FAP)
- Fibroblast activation protein alpha
| - (2S)-1-(2-{[4-(2,3-dihydro-1H-isoindol-2-yl)-2-methyl-4-oxobutan-2-yl]amino}acetyl)pyrrolidine-2-carbonitrile
- (2S)-Cyanopyrrolidine analogue 21d
- (2S)-cyanopyrrolidine 4
- 2-[3-[2-[2-Cyano-(S)-pyrrolidin-1-yl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,3-dihydroisoindole
|
BDBM118134
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Activin receptor type-1
- Activin receptor type-1B
- Activin receptor type-1B/Activin receptor-like kinase 4 (ALK-4)
- Activin receptor-like kinase 3 (ALK-3)
- Bone morphogenetic protein receptor type-1B (BMPR1B) aa 168-495
- Serine/threonine-protein kinase receptor R3
- Serine/threonine-protein kinase receptor R3 (ALK1)
- TGF-beta receptor type-1
| - US10017516, Compound 3
- US9682983, 3
|
BDBM118138
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Activin receptor type-1
- Activin receptor type-1B
- Activin receptor type-1B/Activin receptor-like kinase 4 (ALK-4)
- Activin receptor-like kinase 3 (ALK-3)
- Bone morphogenetic protein receptor type-1B (BMPR1B) aa 168-495
- Serine/threonine-protein kinase receptor R3
- Serine/threonine-protein kinase receptor R3 (ALK1)
- TGF-beta receptor type-1
| - US10017516, Compound 4
- US9682983, 4
|
BDBM11870
 | 5 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | - 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-14 (MMP14)
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
| - 4-{[4-(4-Chlorophenoxy)phenyl]sulfonyl}-N-hydroxy tetrahydro-2H-pyran-4-carboxamide
- 4-{[4-(4-chlorophenoxy)benzene]sulfonyl}-N-hydroxyoxane-4-carboxamide
- alpha-sulfone 21
|
BDBM119440
 | 1 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 6
- Histone deacetylase 1
- Histone deacetylase 10
- Histone deacetylase 11
- Histone deacetylase 2
- Histone deacetylase 3
- Histone deacetylase 4
- Histone deacetylase 5
- Histone deacetylase 7
- Histone deacetylase 8
- Histone deacetylase 9
- Prostaglandin E2 receptor EP2 subtype
| |
BDBM123325
 | 4 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Orexin receptor type 1
- Orexin receptor type 2
- Potassium voltage-gated channel subfamily H member 2
| |
BDBM12355
 | 3 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2A6
- Cytochrome P450 2B6
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 2E1
- Cytochrome P450 3A
| - 3-(thiophen-3-yl)pyridine
- CHEMBL361153
- US8609708,11
- nicotine 3-heteroaromatic analogue 8
|
BDBM127644
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - High affinity nerve growth factor receptor
- JAK2 (aa 808-1132)
- Tyrosine-protein kinase JAK2
| - US10251889, Example 17
- US10758542, Example 17
- US8791123, 17
- US9782415, Example 17
- US9796724, Example 17
|
BDBM127808
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - High affinity nerve growth factor receptor
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| - US8791123, 181
- US9782415, Example 181
|
BDBM127883
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Activin receptor type-1
- Activin receptor type-1B
- Activin receptor type-1B/Activin receptor-like kinase 4 (ALK-4)
- Activin receptor-like kinase 3 (ALK-3)
- Bone morphogenetic protein receptor type-1B (BMPR1B) aa 168-495
- Serine/threonine-protein kinase receptor R3
- Serine/threonine-protein kinase receptor R3 (ALK1)
- TGF-beta receptor type-1
| - US10017516, Compound 6
- US9682983, 6
|
BDBM135812
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| - US10085990, Example 30
- US10568888, Example 30
- US8853226, 30
- US9393245, 30
- US9833457, 30
|
BDBM135813
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| - US10085990, Example 32
- US10568888, Example 32
- US8853226, 32
- US9393245, 32
- US9833457, 32
|
BDBM135814
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| - US10085990, Example 33
- US10568888, Example 33
- US8853226, 33
- US9393245, 33
- US9833457, 33
|
BDBM135815
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| - US10085990, Example 51
- US10568888, Example 51
- US8853226, 51
- US9393245, 51
- US9833457, 51
|
BDBM135816
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| - US10085990, Example 54
- US10568888, Example 54
- US8853226, 54
- US9393245, 54
- US9833457, 54
|
BDBM135817
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| - US10085990, Example 84
- US10568888, Example 84
- US8853226, 84
- US9393245, 84
- US9833457, 84
|
BDBM135818
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| - US10085990, Example 92
- US10568888, Example 92
- US8853226, 92
- US9393245, 92
- US9833457, 92
|
BDBM135820
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| - US10085990, Example 115
- US10568888, Example 115
- US8853226, 115
- US9393245, 115
- US9833457, 115
|
BDBM135821
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| - US10085990, Example 118
- US10568888, Example 118
- US8853226, 118
- US9393245, 118
- US9833457, 118
|
BDBM135824
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| - US10085990, Example 127
- US10568888, Example 127
- US8853226, 127
- US9393245, 127
- US9833457, 127
|
BDBM136570
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Beta-secretase 1
- Cathepsin D
- Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C8
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Potassium voltage-gated channel subfamily H member 2
| |
BDBM139295
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Cereblon/Histone deacetylase 2
- Cereblon/Histone deacetylase 6
- Histone deacetylase 1
- Histone deacetylase 2
- Histone deacetylase 3
| - US10858323, Compound 1
- US8614223, 73
|
BDBM13940
 | 12 | 0 | 0 | 0 | 0 | 0 |